Publications by authors named "Peter Tilston"

Claim this Profile
E
Evaluation of the ® Prep&Amp UM RT-PCR for detection of SARS-CoV-2 from nasopharyngeal swabs without prior nucleic acid eluate extraction.
Robert William O'Hara, Benjamin Brown, Angela Hughes, Ashley McEwan, Andrew Birtles, Peter Tilston

J Clin Virol Plus· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Overview of SARS-CoV-2 Molecular Diagnostics in Europe.
Emma Davies, Hamzah Z Farooq, Benjamin Brown, Peter Tilston, Ashley McEwan

Clin Lab Med· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world SARS CoV-2 testing in Northern England during the first wave of the COVID-19 pandemic.
Hamzah Z Farooq, Emma Davies, Benjamin Brown, Thomas Whitfield, Peter Tilston

J Infect· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Virological outcomes of boosted protease inhibitor-based first-line ART in subjects harbouring thymidine analogue-associated mutations as the sole form of transmitted drug resistance.
Anna Maria Geretti, Ellen White, Chloe Orkin, Anna Tostevin, Peter Tilston

J Antimicrob Chemother· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and clinical impact of respiratory viruses in adults with cystic fibrosis.
William G Flight, Rowland J Bright-Thomas, Peter Tilston, Kenneth J Mutton, Malcolm Guiver

Thorax· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic rhinovirus infection in an adult with cystic fibrosis.
William G Flight, Rowland J Bright-Thomas, Peter Tilston, Kenneth J Mutton, Malcolm Guiver

J Clin Microbiol· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of HIV-1 reverse transcriptase polymorphisms on responses to first-line nonnucleoside reverse transcriptase inhibitor-based therapy in HIV-1-infected adults.
Nicola E Mackie, David T Dunn, David Dolling, Lucy Garvey, Linda Harrison, Peter Tilston

AIDS· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of different definitions on the estimated rate of transmitted HIV drug resistance in the United Kingdom.
Hannah Green, Peter Tilston, Esther Fearnhill, Deenan Pillay, David T Dunn

J Acquir Immune Defic Syndr· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis